Your browser doesn't support javascript.
loading
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Adlhoch, Cornelia; Delgado-Sanz, Concepción; Carnahan, AnnaSara; Larrauri, Amparo; Popovici, Odette; Bossuyt, Nathalie; Thomas, Isabelle; Kyncl, Jan; Slezak, Pavel; Brytting, Mia; Guiomar, Raquel; Redlberger-Fritz, Monika; Maistre Melillo, Jackie; Melillo, Tanya; van Gageldonk-Lafeber, Arianne B; Marbus, Sierk D; O'Donnell, Joan; Domegan, Lisa; Gomes Dias, Joana; Olsen, Sonja J.
Afiliação
  • Adlhoch C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Delgado-Sanz C; National Centre of Epidemiology, CIBERESP, Carlos III Health Institute, Madrid, Spain.
  • Carnahan A; Public Health Agency of Sweden, Stockholm, Sweden.
  • Larrauri A; National Centre of Epidemiology, CIBERESP, Carlos III Health Institute, Madrid, Spain.
  • Popovici O; National Institute of Public Health Romania-National Centre for Communicable Diseases Surveillance and Control, Bucharest, Romania.
  • Bossuyt N; Sciensano, Brussels, Belgium.
  • Thomas I; Sciensano, Brussels, Belgium.
  • Kyncl J; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czechia.
  • Slezak P; Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czechia.
  • Brytting M; Public Health Agency of Sweden, Stockholm, Sweden.
  • Guiomar R; National Influenza Reference Laboratory, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
  • Redlberger-Fritz M; Center for Virology, Medical University Vienna, Vienna, Austria.
  • Maistre Melillo J; Infectious Disease prevention and Control unit, Malta.
  • Melillo T; Infectious Disease prevention and Control unit, Malta.
  • van Gageldonk-Lafeber AB; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Marbus SD; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
  • Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
  • Gomes Dias J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Olsen SJ; WHO Regional Office for Europe, Copenhagen, Denmark.
Euro Surveill ; 28(4)2023 01.
Article em En | MEDLINE | ID: mdl-36700868
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Influenza Humana / Oseltamivir Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Influenza Humana / Oseltamivir Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia